L Annable

4.3k total citations
93 papers, 3.0k citations indexed

About

L Annable is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, L Annable has authored 93 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Psychiatry and Mental health, 18 papers in Pharmacology and 16 papers in Clinical Psychology. Recurrent topics in L Annable's work include Schizophrenia research and treatment (35 papers), Bipolar Disorder and Treatment (18 papers) and Electroconvulsive Therapy Studies (16 papers). L Annable is often cited by papers focused on Schizophrenia research and treatment (35 papers), Bipolar Disorder and Treatment (18 papers) and Electroconvulsive Therapy Studies (16 papers). L Annable collaborates with scholars based in Canada, United States and United Kingdom. L Annable's co-authors include G Chouinard, Guy Chouinard, Réjean Fontaine, Simon N. Young, A Ross‐Chouinard, A.M. Ghadirian, Jacques Bradwejn, L. Solyom, Yves Dion and Paul Sandor and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

L Annable

92 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
L Annable 1.6k 655 568 456 420 93 3.0k
G Chouinard 1.6k 1.0× 631 1.0× 601 1.1× 514 1.1× 702 1.7× 99 2.9k
Eric D. Peselow 1.5k 0.9× 838 1.3× 780 1.4× 485 1.1× 712 1.7× 103 3.5k
Jack G. Modell 1.2k 0.8× 786 1.2× 484 0.9× 644 1.4× 913 2.2× 52 3.6k
Robert M. Post 2.1k 1.3× 662 1.0× 319 0.6× 919 2.0× 333 0.8× 60 3.8k
M. W. P. Carney 1.1k 0.7× 347 0.5× 375 0.7× 261 0.6× 728 1.7× 75 3.0k
Y.D. Lapierre 1.1k 0.7× 521 0.8× 432 0.8× 741 1.6× 560 1.3× 139 2.6k
David G. Daniel 2.7k 1.7× 678 1.0× 524 0.9× 318 0.7× 436 1.0× 91 3.9k
Robert H. Gerner 1.1k 0.7× 660 1.0× 349 0.6× 800 1.8× 509 1.2× 66 3.0k
S.R. Marder 2.4k 1.5× 692 1.1× 602 1.1× 284 0.6× 292 0.7× 45 3.2k
Sukdeb Mukherjee 1.8k 1.1× 400 0.6× 206 0.4× 305 0.7× 289 0.7× 84 3.1k

Countries citing papers authored by L Annable

Since Specialization
Citations

This map shows the geographic impact of L Annable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Annable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Annable more than expected).

Fields of papers citing papers by L Annable

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Annable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Annable. The network helps show where L Annable may publish in the future.

Co-authorship network of co-authors of L Annable

This figure shows the co-authorship network connecting the top 25 collaborators of L Annable. A scholar is included among the top collaborators of L Annable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Annable. L Annable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klein, Marina B., Curtis Cooper, Marie‐Josée Brouillette, et al.. (2008). CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. Contemporary Clinical Trials. 29(4). 617–630. 9 indexed citations
3.
Kin, N.M.K. Ng Ying, N.P.V. Nair, George J. Schwartz, Joseph Thavundayil, & L Annable. (2004). Secretion of Melatonin in Healthy Elderly Subjects: A Longitudinal Study. Annals of the New York Academy of Sciences. 1019(1). 326–329. 16 indexed citations
4.
Pinard, Gilbert, et al.. (2003). Tryptophan, Serotonin and Human Social Behavior. Advances in experimental medicine and biology. 527. 215–224. 17 indexed citations
5.
Dion, Yves, L Annable, Paul Sandor, & Guy Chouinard. (2002). Risperidone in the Treatment of Tourette Syndrome: A Double-Blind, Placebo-Controlled Trial. Journal of Clinical Psychopharmacology. 22(1). 31–39. 151 indexed citations
6.
Joober, Ridha, Guy A. Rouleau, Samarthji Lal, et al.. (2002). Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers. Schizophrenia Research. 53(3). 229–238. 62 indexed citations
7.
Steinberg, Susanne, et al.. (1999). A placebo-controlled clinical trial of l-tryptophan in premenstrual dysphoria. Biological Psychiatry. 45(3). 313–320. 51 indexed citations
8.
Steinberg, Susanne, et al.. (1999). A Placebo-Controlled Study of the Effects of L-Tryptophan in Patients with Premenstrual Dysphoria. Advances in experimental medicine and biology. 467. 85–88. 7 indexed citations
9.
Young, Simon N. & L Annable. (1996). The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.. PubMed. 21(4). 235–8. 11 indexed citations
10.
Klinke, W. Peter, Michael G. Baird, Martin Juneau, et al.. (1995). Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID. Cardiovascular Drugs and Therapy. 9(2). 319–330. 2 indexed citations
11.
Chouinard, G, et al.. (1993). A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.. PubMed. 38 Suppl 4. S114–21. 56 indexed citations
12.
Bradwejn, Jacques, et al.. (1992). A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biological Psychiatry. 32(10). 903–912. 64 indexed citations
13.
Klinke, W. Peter, Martin Juneau, Michael Grace, et al.. (1989). Usefulness of sustained-release diltiazem for stable angina pectoris. The American Journal of Cardiology. 64(19). 1249–1252. 14 indexed citations
14.
Chouinard, G, et al.. (1987). Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.. PubMed. 23(1). 221–6. 13 indexed citations
15.
Chouinard, Guy, et al.. (1979). Ethopropazine and benztropine in neuroleptic-induced parkinsonism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 40(3). 147–52. 52 indexed citations
16.
Chouinard, G, et al.. (1977). Loxapine succinate in the treatment of newly admitted schizophrenic patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(1). 73–9. 3 indexed citations
17.
Chouinard, G, L Annable, & Sally‐Ann Cooper. (1977). Antiparkinsonian drug administration and plasma levels of penfluridol, a new long-acting neuroleptic.. PubMed. 1(4). 325–31. 9 indexed citations
18.
Chouinard, G & L Annable. (1977). The effect of rubidium in schizophrenia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(4). 373–83. 5 indexed citations
19.
Chouinard, Guy, et al.. (1977). Penfluridol in the Maintenance Treatment of Schizophrenic Patients Newly Discharged from A Brief Therapy Unit. The Journal of Clinical Pharmacology. 17(2-3). 162–167. 9 indexed citations
20.
Chouinard, Guy & L Annable. (1976). Clozapine in the Treatment of Newly Admitted Schizophrenic Patients A Pilot Study. The Journal of Clinical Pharmacology. 16(5-6). 289–297. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Chouinard Breakdown of academic impact, for papers by Eric D. Peselow Breakdown of academic impact, for papers by Jack G. Modell Breakdown of academic impact, for papers by Robert M. Post Breakdown of academic impact, for papers by M. W. P. Carney Breakdown of academic impact, for papers by Y.D. Lapierre Breakdown of academic impact, for papers by David G. Daniel Breakdown of academic impact, for papers by Robert H. Gerner Breakdown of academic impact, for papers by S.R. Marder Breakdown of academic impact, for papers by Sukdeb Mukherjee
Rankless by CCL
2026